Filipin recognizes both GM1 and cholesterol in GM1 gangliosidosis mouse brain

Journal of Lipid Research

Volumn 52, Issue 7, 2011, Pages 1345-1351

  Arthur, Julian R ^a   Heinecke, Karie A ^a   Seyfried, Thomas N ^a  

^a BOSTON COLLEGE   (United States)

Author keywords

Cholesterol trafficking; Ganglioside; Lipid raft; Phospholipid phosphatidylcholine; Phospholipid phosphatidylethanolamine; Sphingolipid; Storage disease

Indexed keywords

BETA GANGLIOSIDE; CHOLESTEROL; FILIPIN; GANGLIOSIDE; GANGLIOSIDE GM1; PHOSPHOLIPID; SIALIC ACID; STEROL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN DISEASE; CELL MEMBRANE; CONTROLLED STUDY; GM1 GANGLIOSIDOSIS; HISTOCHEMISTRY; LIPID ANALYSIS; LIPID BRAIN LEVEL; MICROSOME; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; THIN LAYER CHROMATOGRAPHY;

ANIMALS; BIOLOGICAL TRANSPORT; BRAIN; CELL MEMBRANE; CHOLESTEROL; FEMALE; FILIPIN; G(M1) GANGLIOSIDE; GANGLIOSIDES; GANGLIOSIDOSIS, GM1; MALE; MICE; MICROSOMES; STAINING AND LABELING;

EID: 79959224232     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M012633     Document Type: Article

References (54)

1. Whitfield, G. B., T. D. Brock, A. Ammann, D. Gottlieb, and H. E. Carter. 1955. Filipin, an antifungal antibiotic: isolation and properties. J. Am. Chem. Soc. 77: 4799-4801.
2. Gottlieb, D., A. Ammann, and H. E. Carter. 1955. A new antifungal agent, filipin. Plant Dis. Rep. 39: 219.
3. Ammann, A., and D. Gottlieb. 1955. Paper chromatography of antifungal antibiotics. Appl. Microbiol. 3: 181-186.
4. Brock, T. D. 1956. The effect of oils and fatty acids on the production of filipin. Appl. Microbiol. 4: 131-133.
5. Kinsky, S. C. 1961. Alterations in the permeability of Neurospora crassa due to polyene antibiotics. J. Bacteriol. 82: 889-897.
6. Gimpl, G., and K. Gehrig-Burger. 2007. Cholesterol reporter molecules. Biosci. Rep. 27: 335-358.
7. Schroeder, F., J. F. Holland, and L. L. Bieber. 1971. Fluorometric evidence for the binding of cholesterol to the filipin complex. J Antibiot.(Tokyo). 24: 846-849.
8. Norman, A. W., R. A. Demel, D. E. Kruyff, and L. L. M. van Deenan. 1972. Studies on the biological properties of polyene antibiotics. Evidence for the direct interaction of filipin with cholesterol. J. Biol. Chem. 247: 1918-1929.
9. Harzer, K., and B. Kustermann-Kuhn. 2001. Quantified increases of cholesterol, total lipid and globotriaosylceramide in filipinpositve Niemann-Pick type C fibroblasts. Clin. Chim. Acta. 305: 65-73.
10. Te Vruchte, D., E. Lloyd-Evans, R. J. Veldman, D. C. A. Neville, R. A. Dwek, F. M. Platt, W. J. van Blitterswijk, and D. J. Sillence. 2004. Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport. J. Biol. Chem. 279: 26167-26175.
11. Pham, N. A., M. R. Gal, R. D. Bagshaw, A. J. Mohr, B. Chue, T. Richardson, and J. W. Callahan. 2005. A comparative study of cytoplasmic granules imaged by the real-time microscope, Nile Red, and filipin in fibroblasts from patients with lipid storage disorders. J. Inherit. Metab. Dis. 28: 991-1004.
12. Yanagisawa, K. 2003. Cholesterol and A beta aggregation. Pharmacopsychiatry. 36 (Suppl.): 127-129.
13. Broekman, M. L., R. C. Baek, L. A. Comer, J. L. Fernandez, T. N. Seyfried, and M. Sena-Esteves. 2007. Complete correction of enzymatic deficiency and neurochemistry in the GM1-gangliosidosis mouse brain by neonatal adeno-associated virus-mediated gene delivery. Mol. Ther. 15: 30-37.
14. Trushina, E., R. B. Dyer, J. D. Badger II, D. Ure, L. Eide, D. D. Tran, B. T. Vrieze, V. Legendre-Guillemin, P. S. McPherson, B. S. Mandavilli, et al. 2004. Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol. Cell. Biol. 24: 8195-8209.
15. Puri, V., R. Watanabe, M. Dominguez, X. Sun, C. L. Wheatley, D. L. Marks, and R. E. Pagano. 1999. Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid storage diseases. Nat. Cell Biol. 1: 386-388.
16. Smejkal, G. B., G. Hoppe, and H. F. Hoff. 1996. Filipin as a fluorescent probe of lipoprotein-derived sterols on thin-layer chromatograms. Anal. Biochem. 239: 115-117.
17. Hoppe, G., A. Ravandi, D. Herrera, A. Kuksis, and H. F. Hoff. 1997. Oxidation products of cholesteryl linoleate are resistant to hydrolysis in macrophages, form complexes with proteins, and are present in human atherosclerotic lesions. J. Lipid Res. 38: 1347-1360.
18. Norden, A. G., and J. S. O'Brien. 1975. An electrophoretic variant of beta-galactosidase with altered catalytic properties in a patient with GM1 gangliosidosis. Proc. Natl. Acad. Sci. USA. 72: 240-244.
19. Kasperzyk, J. L., M. M. El-Abbadi, E. C. Hauser, A. d'Azzo, F. M. Platt, and T. N. Seyfried. 2004. N-butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis. J. Neurochem. 89: 645-653.
20. Brunetti-Pierri, N., and F. Scaglia. 2008. GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects. Mol. Genet. Metab. 94: 391-396.
21. Hauser, E. C., J. L. Kasperzyk, A. d'Azzo, and T. N. Seyfried. 2004. Inheritance of lysosomal acid β-galactosidase activity and gangliosides in crosses of DBA/2J and knockout mice. Biochem. Genet. 42: 241-257.
22. Tessitore, A., M. del P. Martin, R. Sano, Y. Ma, L. Mann, A. Ingrassia, E. D. Laywell, D. A. Steindler, L. M. Hendershot, and A. d'Azzo. 2004. GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis. Mol. Cell. 15: 753-766.
23. Kasperzyk, J. L., A. d'Azzo, F. M. Platt, J. Alroy, and T. N. Seyfried. 2005. Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice. J. Lipid Res. 46: 744-751.
24. D'Azzo, A., A. Tessitore, and R. Sano. 2006. Gangliosides as apoptotic signals in ER stress response. Cell Death Differ. 13: 404-414.
25. Sano, R., I. Annunziata, A. Patterson, S. Moshiach, E. Gomero, J. Opferman, M. Forter, and A. d'Azzo. 2009. GM1-ganglioside accumulation at the mitochondria-associated ER membranes links ER stress to Ca2+-dependent mitochondrial apoptosis. Mol. Cell. 36: 500-511.
26. Watanabe, Y., S. Akaboshi, G. Ishida, T. Takeshima, T. Yano, M. Taniguchi, K. Ohno, and K. Nakashima. 1998. Increased levels of GM2 ganglioside in fibroblasts from a patient with juvenile Niemann-Pick disease type C. Brain Dev. 20: 95-97. (Pubitemid 28130235)
27. Walkley, S. U. 2004. Secondary accumulation of gangliosides in lysosomal storage disorders. Semin. Cell Dev. Biol. 4: 433-444.
28. McGlynn, R., K. Dobrenis, and S. Walkley. 2004. Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders. J. Comp. Neurol. 480: 415-426.
29. Xu, Y. H., S. Barnes, Y. Sun, and G. A. Grabowski. 2010. Multisystem disorders of glycosphingolipid and ganglioside metabolism. J. Lipid Res. 51: 1643-1675.
30. Puri, V., J. R. Jefferson, R. D. Singh, C. L. Wheatly, D. L. Marks, and R. E. Pagano. 2003. Sphingolipid storage induces accumulation of intracellular cholesterol by stimulating SREBP-1 cleavage. J. Biol. Chem. 278: 20961-20970.
31. Glaros, E. N., W. S. Kim, C. M. Quinn, J. Wong, I. Gelissen, W. Jessup, and B. Garner. 2005. Glycosphingolipid accumulation inhibits cholesterol efflux via the ABCA1/apolipoprotein A-I pathway: 1-phenyl-2-decanoylamino-3-morpholino- 1-propanol is a novel cholesterol efflux accelerator. J. Biol. Chem. 280: 24515-24523.
32. Gondre-Lewis, M. C., R. McGlynn, and S. U. Walkley. 2003. Cholesterol accumulation in NPC1-deficient neurons is ganglioside dependent. Curr. Biol. 13: 1324-1329.
33. Jeyakumar, M., R. A. Dwek, T. D. Butters, and F. M. Platt. 2005. Storage solutions: treating lysosomal disorders of the brain. Nat. Rev. Neurosci. 6: 713-725.
34. Simons, K., and J. Gruenberg. 2000. Jamming the endosomal system: lipid rafts and lysosomal storage diseases. Trends Cell Biol. 10: 459-462.
35. Kaiser, H. J., D. Lingwood, I. Levental, J. L. Sampaio, L. Kalvodova, L. Rajendran, and K. Simons. 2009. Order of lipid phases in model and plasma membranes. Proc. Natl. Acad. Sci. USA. 106: 16645-16650.
36. Arthur, J. A., and T. N. Seyfried. 2010. Relationship of filipin staining, GM1 content, and cholesterol in GM1 gangliosidosis. American Society for Neurochemistry 41 st Annual Meeting. 2010 March 6-10. Santa Fe, NM. p 12. Abstract PSM05-05.
37. Hahn, C. N., M. del Pilar Martin, M. Schröder, M. T. Vanier, Y. Hara, K. Suzuki, K. Suzuki, and A. d'Azzo. 1997. Generalized CNS disease and massive GM1-ganglioside accumulation in mice defective in lysosomal acid beta-galactosidase. Hum. Mol. Genet. 6: 205-211.
38. Galjaard, H. 1979. Early diagnosis and prevention of genetic disease. Ann. Clin. Biochem. 16: 343-353.
39. Lomnitski, L., L. Oron, D. Sklan, and D. M. Michaelson. 1999. Distinct alterations in phospholipid metabolism in brains of apoliprotein E-deficient mice. J. Neurosci. Res. 58: 586-592.
40. Kiebish, M. A., X. Han, H. Cheng, A. Lunceford, C. F. Clarke, H. Moon, J. H. Chuang, and T. N. Seyfried. 2008. Lipidomic analysis and electron transport chain activities in C57BL/6J mouse brain mitochondria. J. Neurochem. 106: 299-312.
41. Macala, L. J., R. K. Yu, and S. Ando. 1983. Analysis of brain lipids by high performance thin-layer chromatography and densitometry. J. Lipid Res. 24: 1243-1250. (Pubitemid 14236574)
42. Beknke, O., J. Tranum-Jensen, and B. van Deurs. 1984. Filipin as a cholesterol probe. I. Morphology of filipin-cholesterol interaction in lipid model systems. Eur. J. Cell Biol. 35: 189-199.
43. Brante, G. 1952. Gargoylism: a mucopolysaccharidosis. Scand. J. Clin. Lab. Invest. 4: 43-46.
44. Heinecke, K. A., B. N. Peacock, B. R. Blazar, J. Tolar, and T. N. Seyfried. 2011. Lipid composition of whole brain and cerebellum in Hurler syndrome (MPS IH) mice. Neurochem. Res. Epub ahead of print. January 2011. doi: 10.1007/s11064-011-0400-y.
45. Davidson, C. D., N. F. Ali, M. C. Micsenyi, G. Stephney, S. Renault, K. Dobrenis, D. S. Ory, M. T. Vanier, and S. U. Walkley. 2009. Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression. PLoS ONE. 4: E6951.
46. Abi-Mosleh, L., R. E. Infante, A. Radhakrishnan, J. L. Goldstein, and M. S. Brown. 2009. Cyclodextrin overcomes deficient lysosometo-endoplasmic reticulum transport of cholesterol in Niemann-Pick type C cells. Proc. Natl. Acad. Sci. USA. 106: 19316-19321.
47. Liu, B., C. M. Ramirez, A. M. Miller, J. J. Repa, S. D. Turley, and J. M. Dietschy. 2010. Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid. J. Lipid Res. 51: 933-944.
48. Kasama, T., and T. Taketomi. 1986. Abnormalities of cerebral lipids in GM1-gangliosidoses, infantile, juvenile, and chronic type. Jpn. J. Exp. Med. 56: 1-11.
49. Orlandi, P. A., and P. H. Fishman. 1998. Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J. Cell Biol. 141: 905-915.
50. Sugimoto, Y., H. Ninomiya, Y. Ohsaki, K. Higaki, J. P. Davies, Y. A. Ioannou, and K. Ohno. 2001. Accumulation of cholera toxin and GM1 ganglioside in the early endosome of Niemann-Pick C1- deficient cells. Proc. Natl. Acad. Sci. USA. 98: 12391-12396.
51. Mellgren, R. L. 2007. Detergent-resistant membrane subfractions containing proteins of plasma membrane, mitochondrial, and internal membrane origins. J. Biochem. Biophys. Methods. 70: 1029-1036.
52. Adam, R. M., W. Yang, D. Di Vizio, N. K. Mukhopadhyay, and H. Steen. 2008. Rapid preparation of nuclei-depleted detergent-resistant membrane fractions suitable for proteomics analysis. BMC Cell Biol. 9: 30.
53. Bergy, M. E., and T. E. Eble. 1968. The filipin complex. Biochemistry. 7: 653-659.
54. Richardson, T. I., and S. D. Rychnovsky. 1996. Filipin III: configuration assignment and confirmation by synthetic correlation. J. Org. Chem. 61: 4219-4231.